Imaging/Diagnostics News

After reading “Surgeon outlines reasons not to treat pre-perimetric glaucoma suspects” (March 2012, page 6), which covered a presentation at Hawaiian Eye 2012 by Kuldev Singh, MD, my only rational conclusion was that this was printed a month early, as it is appropriate only as an April Fools’ piece.

As a noninvasive substitute for fluorescein angiography, OCT angiography will improve patient compliance, monitoring of disease progression and treatment outcomes.

Welcome to CEDARS-ASPENS Debates, a monthly feature in Ocular Surgery News.

Novel IOL technologies and increasing patient expectations for precise refractive results have driven a series of innovations in biometry and IOL power calculation. Notable improvements have been seen in recent years, and about 1,000 citations for optical biometry currently appear in PubMed.